跳至主要内容
临床试验/NCT04745273
NCT04745273已完成4 期

The Effect of Ondansetron on the Efficacy of Tramadol

Acibadem University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年9月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Interaction

研究概览

简要总结

In the postoperative period; pain, nausea, and vomiting are undesirable side effects that reduce the patient's comfort and may lead to various complications. Ondansetron is frequently used as an antiemetic and tramadol hydrochloride is used for postoperative analgesia in laparoscopic cholecystectomy. However, some studies have reported that there is a drug interaction between these two drugs and they reduce each other's effects, thus requiring more analgesics in the postoperative period.

The aim of this study is; To evaluate whether ondansetron reduces the analgesic efficacy of tramadol hydrochloride in laparoscopic cholecystectomies.

详细描述

During the operation, 4 mg iv ondansetron (2mL) will be administered to the ondansetron group and 2mL iv 09% saline will be administered to the placebo group. The patients' heart rate, blood pressure, oxygen saturation, sedation score (with Ramsey Seading Score), amount of pain (with NRS), degree of nausea (with NRS), whether there is vomiting, whether analgesic or antiemetic treatment is required, and the amount of tramadol use will be recorded at 1, 2, 4, 8, 12 and 24 hours in the postoperative period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 60 patients over the age of 18, ASA I-II, undergoing laparoscopic cholecystectomy

排除标准

  • Patients under 18 years of age
  • Patients with known allergies to the drugs to be used
  • Pregnant and breastfeeding mothers
  • Patients who received antiemetic or cortisone within 24 hours before surgery
  • Patients with mental illness or epilepsy
  • Patients with alcohol or substance abuse

研究组 & 干预措施

Ondansetron

Active Comparator

Participants will receive Kemoset 4 mg iv intraoperatively

干预措施: Ondansetron 4 MG (Kemoset 4mg) (Drug)

Salin solution

Placebo Comparator

Participants will receive Salin solution 2ml (iv) intraoperatively

干预措施: Salin solution (Other)

结局指标

主要结局

Interaction

时间窗: 24 hours

The hypothesis of this study is that if ondanstron is given together with tramadol peroperatively, tramadol consumption is increase postoperatively due to tramadol ondansetron interaction. The primary outcome measure is consumption of tramadol postoperatively for 24 hours.

次要结局

未报告次要终点

研究者

发起方
Acibadem University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sevgi Bilgen

Associate professor

Acibadem University

研究点 (1)

Loading locations...

相似试验